Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Operating Expenses | 1,584 | 2,939 | 4,524 | 4,293 | 4,149 |
| Operating Income | -1,584 | -2,939 | -4,524 | -4,293 | -4,149 |
| Other Income | -81 | -24 | -43 | 158 | 96 |
| Pre-tax Income | -1,665 | -2,963 | -4,567 | -4,135 | -4,053 |
| Income Tax | -56 | -192 | -400 | -21 | 0 |
| Net Income Continuous | -1,609 | -2,771 | -4,167 | -4,114 | -4,053 |
| Minority Interests | -946 | 0 | 0 | -193 | -473 |
| Net Income | $-663 | $-2,771 | $-4,167 | $-3,921 | $-3,580 |
| EPS Basic Total Ops | -20.00 | -70.00 | -100.00 | -100.00 | -90.00 |
| EPS Basic Continuous Ops | -39.35 | -67.78 | -101.92 | -100.62 | -99.15 |
| EPS Diluted Total Ops | -20.00 | -70.00 | -100.00 | -100.00 | -90.00 |
| EPS Diluted Continuous Ops | -39.35 | -67.78 | -101.92 | -100.62 | -99.15 |
| EPS Diluted Before Non-Recurring Items | N/A | -70.00 | -100.00 | -100.00 | N/A |
| EBITDA(a) | $-1,405 | $-2,782 | $-4,364 | $-4,120 | $-4,120 |